Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multi Criteria Decision Analysis.

Medha BarbhaiyaStephane ZuilyMary-Carmen AmigoDanieli AndradeTadej AvcinMaria Laura BertolacciniD Ware BranchNathalie Costedoat-ChalumeauMark CrowtherGuilherme Ribeiro Ramires de JésusKatrien M J DevreeseCamille FrancesDavid GarciaJosé A Gómez-PuertaFrancis GuilleminSteven R LevineRoger A LevyMichael D LockshinThomas L OrtelMichelle A PetriGiovanni SannaSavinio SciasciaSurya V SeshanMaria G G TektonidouDenis WahlRohan WillisCecile M YelnikAlison HendryRay NadenKaren H Costenbader Doruk Erkannull null

Published in: Arthritis care & research (2024)

Using MCDA, candidate criteria preliminary weights were determined. Unlike other disease classification systems using a single aggregate threshold score, separate clinical and laboratory domain thresholds were incorporated into the new APS classification criteria.

Keyphrases

deep learning
machine learning
phase iii
clinical trial
open label
randomized controlled trial
phase ii